Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Subdural Effusion

ClinicalTrials.gov lists 3 trials for Subdural Effusion or a narrower condition beneath it. Integra LifeSciences Corporation has the most among industry and government lead sponsors, with 1.

MeSH D013353 Infections C01 C10
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Trials started per year Trials started per year 3 Trials by phase Trials by phase 1 Trials by recruitment status Trials by recruitment status 2 Lead sponsors Lead sponsors 1 Serious adverse events in this condition's trials Serious adverse events in this condition's trials 10 Publications Publications 15 Trials started per year Trials started per year 3 Trials by phase Trials by phase 1 Trials by recruitment status Trials by recruitment status 2 Lead sponsors Lead sponsors 1 Serious adverse events in this condition's trials Serious adverse events in this condition's trials 10 Publications Publications 15

Rows recorded per section

3 sections measured, none recorded · 1 not measured yet · 1 not computed

3 of the 3 trials are tagged with Subdural Effusion itself; the rest are tagged with a narrower condition beneath it.

Get the Subdural Effusion report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Subdural Effusion trials start? (3)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Not applicable

Top of scale: 1

2003: 1 trials (Not applicable 1) 2007: 1 trials (Not applicable 1) 2024: 1 trials (Not applicable 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2024 1
2007 1
2003 1

No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: none of the 3 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Subdural Effusion trials in? (1)

Shown in this order: phase order.

Trials by phase
Phase Trials
Not applicable 3

How many Subdural Effusion trials are recruiting? (2)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Not yet recruiting 1
Completed 2

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Subdural Effusion trials? (1)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
Integra LifeSciences Corporation 1

Which serious adverse events do Subdural Effusion trials report? (10)

Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.

Serious adverse events in this condition's trials
Adverse event Subjects affected Trials
Cerebrospinal Fistula 4 1
Pseudomeningocele 3 1
Chemical Meningitis 2 1
Headache 2 1
Incision Site Haematoma 2 1

Which publications cover Subdural Effusion? (15)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.

Not computed for conditions with fewer than 10 trials: drugs tested.

Browse all condition evidence pages